| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |